New Alzheimer's Drug on the Horizon

There's finally a glimmer of hope in the treatment of Alzheimer's disease. Boston area pharmaceutical company, Biogen, announced that it has submitted results from clinical trials of it's drug, aducanumab, to the US Food and Drug Administration for approval. If approved, aducanumab will be the first drug approved to treat Alzheimer's disease since 2003.  Click here to read the full article

 

CWF_Leaderstat_Ganzhorn_4-3791